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Abstract
De novo mutations (DNM) are an important source of rare variants and are increasingly
being linked to the development of many diseases. Recently, the paternal age effect has
been the focus of a number of studies that attempt to explain the observation that increas-
ing paternal age increases the risk for a number of diseases. Using disease-free familial
quartets we show that there is a strong positive correlation between paternal age and germ-
line DNM in healthy subjects. We also observed that germline CNVs do not follow the same
trend, suggesting a different mechanism. Finally, we observed that DNM were not evenly
distributed across the genome, which adds support to the existence of DNM hotspots.
Introduction
Untill recently, little was known about the global prevalence of de novomutations (DNM), and
the factors that influence their rate of occurence. Some studies suggested that different factors
such as pollution, tobacco smoke or magnetic field could impact the globalmutation rate [1–
3], but it was not possible to assess these on a genome-wide scale, or to look at different classes
of DNM. New sequencing technologies now allow the interrogation of the full genome by
sequencing. Using these technologies, it was recently demonstrated that paternal age effect
(PAE) modulates the DNM rate in patients with psychiatric disorders[4, 5]. Here, we replicate
these finding in ten disease free twin quartets. We show that rate of germline de novo single
nucleotide variants (SNV) and indels but not CNV are associated with parental age. We also
confirm the existence of DNM hotspots, suggesting newmechanisms for the occurrence of
newmutations.
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Methods
Recruitment
All patients gave informed consent in written form to participate in the Quebec Study of New-
born Twins. Ethic boards from the Centre de Recherche du CHUM, from the Université Laval
and from the Montreal Neurological Institute approved this study. Amongst the cohort of the
QSNT, we selected five families with young father at conception (range from 20–25) and five
families with older father at conception (range from 40–47). The cohort did not allow us to
select families with similar maternal age at conception for the two groups (range of 19–25 for
the young father group and range of 30–36 for the older father group) (Table 1).
Sequencing
DNA from the 40 individuals was extracted directly from blood provided by the QSNT.
Libraries were constructed using standard Illumina protocols. Sequencingwas done on an
Illumina HiSeq 2500 at Illumina sequencing facilities. Paired-end mode was used and the
median fragment length was found to be ~300 bp for each individuals. Sequencingwas per-
formed until every sample reached an average coverage of 30x. For DNM rate calculation,
only genome position with sufficient coverage (>20x) in both twins were kept for analysis
(Table 1).
Table 1. Summary of DNM found for each twin quartet.
Group Family
ID
Paternal
Age
Maternal
Age
Twins Base pair
with coverage
>20x (in Gbp)
DNM germline FP Rate Global germline
DNM Rate*
Group 1
TQ1 45.27 30.15 Twin1 2,779 142 16,67% 2,14E-08
Twin2 2,776
TQ2 47.15 30.36 Twin1 2,779 96 10,99% 1,54E-08
Twin2 2,779
TQ3 41.42 31.99 Twin1 2,795 91 14,29% 1,41E-08
Twin2 2,789
TQ4 40.8 36.77 Twin1 2,779 117 20,00% 1,69E-08
Twin2 2,779
TQ5 42 34.68 Twin1 2,779 121 10,99% 1,94E-08
Twin2 2,776
old father global
DNM rate
1,74E-08
Group 2
TQ6 25.8 26.5 Twin1 2,795 60 10,00% 9,75E-09
Twin2 2,795
TQ7 24.8 19.91 Twin1 2,795 71 15,38% 1,08E-08
Twin2 2,792
TQ8 23.55 21.81 Twin1 2,779 77 10,99% 1,24E-08
Twin2 2,779
TQ9 20.73 21.56 Twin1 2,779 58 10,99% 9,32E-09
Twin2 2,789
TQ10 21.96 19.98 Twin1 2,795 56 23,08% 7,78E-09
Twin2 2,792
young father
global DNM rate
1,00E-08
*The Global germline DNM rate was corrected with the appropriated FP value for each family
doi:10.1371/journal.pone.0164212.t001
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SNP Genotyping
Genotyping was done using the Illumina HumanOmni2.5 genotyping arrays.
CNV Genotyping
Log R Ratio (LRR) and B Allele Frequencies (BAF) were extracted by GenomeStudio (version
2011.1) from Illumina HumanOmni2.5 BeadChips using default parameters. CNVs were iden-
tified using QuantiSNP (version 2.3)[6] with local GC correction (hg19) and default parame-
ters. For de novomutations, putative CNV regions were created using the twins’ calls of any
length but with a logarithm of the Bayes factor higher than 10. Only regions with higher than
25% reciprocal overlap found in both the twins were kept for further analysis. From this set,
regions showing any sign of presence in one of the two parents (raw calls) or with an overlap
with any regions found in the Database of Genomic Variants (DGV, version 10, November
2010) were discarded.
SNV and indels calling
We received sequences from Illumina in the form of alignment (bam) files and variant (vcf)
files. In order to have consistent metrics we applied our own bioinformatics pipeline and used
the same genome reference (GRCh37), so we can compare with previous runs.We extracted
the reads and created pools of 20M reads using Picard SAMtoFastq in order to optimise the
use of our computing farm. Each of these pools were aligned using a modified version of the
Burrows-Wheeler Aligner (bwa version 0.6.2-r126-tpx)[7] with threading enabled). The
options were 'bwa aln -t 12 -q 5' and 'bwa sampe -t 12'. Next we recombined the pools in a sin-
gle alignment (bam) file using Picard MergeSamFiles. The realignment method took roughly
36 hours walltime to complete.
We used the realigned bam file in GATK 1.6[8] to process the data with indel realignments,
read duplicates removal and quality score recalibration.We made use of the scatter-gather
mechanism in GATK to accelerate the process; walltime for these operations was around 40
hours. Once all 40 samples were processed, we generated QCmetrics using GATK DepthOf-
Coverage and custom scripts (https://bitbucket.org/mugqic/mugqic_pipelines).
We used GATK UnifiedGenotyper to call SNVs and Indels in a run containing all samples,
and splitting by chromosome to accelerate the process on the cluster. Finally, the variants were
filtered and ordered using GATK Variant Recalibration, which assigns a validity score to each
variant using a training algorithm. For this purposewe strictly followed the procedure from the
Broad Institute (https://www.broadinstitute.org/gatk/guide/best-practices.php).
Once the variant calls were produced, these were compared to the SNP-chip calls; all sam-
ples had a variant concordance higher than 99.5%.
WGS identification of SV
In order to achieve high-confidence structural variants calls for our samples, two different algo-
rithms were used. The first one, CNVer v0.8.1[9], uses information from the paired-endmap-
pings and from the depth of coverage in a given region to call CNVs (insertions and deletions).
Prior to the mapping, the FastqMcf v1.1.2 (https://code.google.com/p/ea-utils/wiki/FastqMcf)
utility was used to detect and remove fragments from sequencing adapters and primers and to
remove poor quality bases at the end of reads. The Bowtie v0.12.9[10] aligner was then used
with the “-v -2 –a–m 600—best—strata” options, as specifiedby the CNVer authors. To reduce
the number of false positives, CNVs called by CNVer were merged when the distance to their
neighbor was fewer than 5 kilobases.
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The second algorithm, BreakDancer[11], uses paired-endmappings signatures to identify
different types of structural variants, including insertions, deletions, inversions and transloca-
tions. The reads were processed as described in the SNV and indels calling section before using
BreakDancerMax (cpp implementation, version 1.1.2) to call structural variants. Once again,
CNVs were merged with a 5 kilobase proximity threshold.
The germline DNM detection and exclusion from this dataset required a maximum overlap
between every twin and his parents of 1% and a minimum overlap to the other twin of 90%.
Sanger sequencing validation
Primers were designed using in-house scripts and the Batch Primer 3 web tool (http://probes.
pw.usda.gov/batchprimer3/) using enough flanking sequence to have a good coverage of
selected variants. PCR was performed using the AmpliTaq Gold DNA Polymerase (Applied
Biosystems) according to the manufacturer’s instructions. To visualize DNA fragments, a small
fraction of the PCR product was loaded on a 1.5% agarose gel containing ethidium bromide.
PCR products were sequenced at the GenomeQuebec Innovation Centre using a 3730XL
DNAnalyzer (Applied Biosystems), and SeqMan from the DNAstar suite was used for muta-
tion detection analysis.
Results
In order to evaluate the effect of paternal age on the rate of DNM in healthy subjects, we
selected ten families consisting of two monozygotic twins and their parents. All individuals
were recruited by the Quebec Study of Newborn Twins (QSNT) project[12]. These families
have been prospectively followed since birth and no severe health conditions were reported for
the twins, now all around 15 years old. These families were selected according to extremes in
paternal age at the time of conception. A group of 5 younger-aged fathers (mean = 23.37±SD
2.06) and 5 older-aged fathers (mean = 43.33±SD2.75) (Table 1) were sequenced. Paternal age
at conception was significantly different between the two groups (t-test, p-value< 1.0010−5).
Despite our efforts to select comparably aged mothers, there was also a small but statistically
significant difference in maternal age at conception (t-test, p-value< 0.0065). Thus, we will be
able to directly assess the effect of parental age effect on DNM variability and we will need to
establish parental origin of mutations to directly implicate the paternal or maternal age.
Whole Genome Sequencing (WGS) was performed on all 40 family members from the 10
families.Mutation detectionwas performed using an in-house bioinformatics pipeline to opti-
mize the detection of variants present in the twins against the variant profiles of the parents.
All samples were genotyped using Illumina HumanOmni2.5 BeadChips and the SNP calls
were used to calibrate and validate variant detectionwith theWGS bioinformatics pipeline. de
novo CNVs were identified using data from the Illumina SNP-chips as well as from theWGS
data using two different algorithms[9, 11]. Consistent DNMs in a twin pair were categorized as
germline (i.e. inherited from gamete cells of one of the parents), while DNM found in a single
twin were categorized as post-zygotic (i.e. mutations happening post-conception).
Overall, 889 germlinemutations and 106 post-zygoticmutations were detected using these
criteria in the 10 twin pairs (S1 Table). In order to test the validity of our in silico detection
pipeline, we tested a subset of the DNM identified using Sanger Sequencing. The proportion of
SVs and indels validated was based on the total proportion observed in the full dataset. A total
of 91 germline variants as well as 62 post-zygotic variants were tested using Sanger sequencing
in the corresponding quartet. Almost 88% of the germline SNV variants were validated while
the indels validation rate was slightly better at 93.5%. Based on these results, we calculated a
false positive rate for each quartet and we used these individual rates to correct the total
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number of DNM. For family quartets for which no false positive was identified, we corrected
with the overall false positive rate of 10.9%. For the post-zygotic variants, only 9 of 62 variants
were confirmed, resulting in a false positive rate higher than 85%. Thus, given that we would
predict that we have detected only 15 post-zygotic DNM, it is impossible to arrive at any con-
clusions regarding post-zygotic DNM rates, except to say that they are in limited number when
looking at DNA extracted from blood.
Assuming a single mutation event for all SNV and indels germlinemutations and collapsing
all twin pairs to a single individual, we calculated the germline de novomutation rate to be
1.3710−8, which is higher than the previously reported rate of 1.110−8.[13]. However, when
stratified by paternal age, the estimated DNM rate in the groups of younger and older fathers
respectively were 1.0110−8 and 1.7410−8 (Rao-Scott chi-square p = 1.3810−12)(Table 1). We
then looked at the CNVDNM rates. CNVs were identified using three different methods, one
using the SNP genotyping arrays and two using algorithms that predict CNVs from the, one
focussing on the depth of coverage information (CNVer) and another that uses read pairs
mapped with unexpected distance or orientation (BreakDancer). For the three algorithms, we
kept only CNVs that had an overlap >90% in the two twins and no overlap at all with the
parents. As getting a consensus for CNV is not trivial and was not needed here, we tested for
parental age effect on each separate dataset without building a consensus dataset. The results
were all concordant and no association with parental age was seen for any method (Table 2)
We next sought to find if there was a specific association between parental sex and the vari-
ability in DNM rate. We found that there was a strong correlation between the germlineDNM
and paternal age (Poisson regression R2 = 0.78, p = 0.00066) as well as with maternal age (Pois-
son regression R2 = 0.65, p = 0.004), though the effect size is smaller for the later. Then, we
tested for parental effect looking separately at single nucleotide variants (SNV) and small inser-
tions and deletions (indels) (Fig 1). We found a strong correlation between paternal age and
single nucleotide germlineDNM variants (Spearman correlation R = 0.7695, p = 0.0092). This
correlation was also observed in the mother, although not as strong (Spearman correlation
R = 0.745, p = 0.013) suggesting that parental age accounts for an important portion of the var-
iability in the DNM rate. A positive correlation was also found for indel germline variants for
both paternal (Spearman correlation R = 0.7631, p = 0.01) and maternal age (Spearman corre-
lation R = 0.702, p = 0.0237). The weaker association with indels could in part result from the
lower power due to the comparatively less frequent occurrence. This observation is nonetheless
Table 2. CNVs identified for each family.
Group Family ID Paternal Age Maternal Age QuantiSNP Loss QuantiSNP Gain CNVer Gain CNVer Loss BreakDancer Loss*
Group 1
TQ1 45,27 30.15 8 6 1 10 3
TQ2 47,15 30.36 7 4 4 6 4
TQ3 41,42 31.99 2 3 4 9 5
TQ4 40,8 36.77 1 3 3 6 7
TQ5 42 34.68 0 1 5 6 5
Group 2
TQ6 25,8 26.5 2 0 5 7 4
TQ7 24,8 19.91 4 3 2 4 7
TQ8 23,55 21.81 2 9 5 5 1
TQ9 20,73 21.56 3 5 2 7 3
TQ10 21,96 19.98 4 4 3 10 6
*Breakdancer was not able to confidently identify gain in our dataset
doi:10.1371/journal.pone.0164212.t002
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in concordance with other studies[4, 5]. Interestingly, germline de novo CNVs show no associ-
ation with parental age (Fig 2) (Student T test> 0.05 for all five comparisons). Although fur-
ther validation is required, this would suggest that the mechanisms explaining the increasing
rate of SNV DNMwith increasing parental age do not apply to CNVs, which may have impli-
cations in our understanding of this phenomenon.
In order to separate out the paternal and maternal age effects, we used individualWGS
reads to assign parental origin of the germline DNM.Working only with germline SNVs, as
they were more frequent than indels, we assigned parental origin according to co-transmission
Fig 1. Association of parental age with germline DNM. This figure shows the correlation between different SNV and indel germline
DNM (left: germline SNV, right: germline indels) with parental age (Top: paternal age, bottom: maternal age). The X-axis represents the
parental age at conception. The Y-axis represents the number of DNM mutations identified through Whole Genome Sequencing.
doi:10.1371/journal.pone.0164212.g001
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of DNM with polymorphisms on single sequence reads. Out of 765 DNM, we were able to
trace parental origin for 57 DNM. Of those, 43 DNMwere of paternal origin and 14 were of
maternal origin; providing an estimated paternal:maternal ratio of ~ 3:1 in our dataset. When
limiting the comparison to the younger paternal age group, we see 16 paternal germlineDNM
and 5 maternal germlineDNM (ratio of ~ 3:1) whereas the older paternal group has 27 pater-
nal germlineDNM and 9 maternal germline DNM (ratio of ~ 3:1). These data suggest that
DNM rates increase both with maternal and paternal age, though the paternal age explains a
greater number of DNMs than maternal age.
Discussion
Many groups have shown an association of de novomutations (DNM) to neurodevelopmental
disorders, notably intellectual disability (ID)[14], autism spectrumdisorder (ASD)[15–17] and
schizophrenia[18–20]. At the time these studies were published, it was yet unclear whether the
DNM rate was fixed across our species or if it was subject to variation. Interestingly, it was pre-
viously shown that paternal age at conception is positively correlated with risk of schizophre-
nia[21, 22].
Fig 2. Association of parental age with CNV called by different algorithms. We used three different algorithms to detect CNV
in our dataset. QuantiSNP was used for genotyping assays while CNVer and BreakDancer were used for WGS. Although the
number varies according to which algorithm was used, no difference between young parental age group and old parental group
can be detected.
doi:10.1371/journal.pone.0164212.g002
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In this study, we show that parental age, more specifically paternal age, explains a major
portion of the variation in the germlineDNM rate. Contrary to other studies that have reported
similar findings, we have studied disease free families, and we have isolated the germlineDNM
rate from post-zygoticmutations with respect to parental age[4, 5]. In our study, fathers aged
40 or greater had a rate of germline DNM that was almost twice as high as that of fathers aged
twenty years younger. We also observe a smaller, yet significant increase in the mutation rate
associated with maternal age. Although we were not able to fully account for age-dependent
sex-effect because of assortative mating present in our families, the origin of mutation suggests
that older maternal age also leads to an increase in DNM. This conclusion is also supported by
other studies that also report a maternal age effect on DNM rate[23–25]. The rates that we
observed in this study are comparable to the rates reported previously[4, 5]. These findings do
not appear to apply to CNVs.We have observed that the CNV rate does not vary with parental
age. This is not a surprising finding as it is known that CNV and SNV have different mecha-
nism or origin although the technical variation observed specifically for CNV in this study
does not permit to fully exclude the link betweenCNV and parental age. It is thought that most
CNVs in the human genome arise from non-allelic homologous recombination while a vast
majority of the SNVs occur during DNA replication[26]. The implications of these findings are
important, as an increasedDNM rate could impact a number of Mendelian and complex
genetic disorders. A study design that includes the DNA of two parents and their children has
proved a valuable approach for the investigation of DNM. The ability to assess DNM rates
offers a valuable means to further characterize the impact of rare variants on diseases and traits
and should be encouraged in the design of future studies where parents are available.
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